External beam radiotherapy in thyroid carcinoma: Clinical review and recommendations of the AIRO "Radioterapia Metabolica" Group

M. Mangoni, C. Gobitti, R. Autorino, L. Cerizza, C. Furlan, R. Mazzarotto, F. Monari, G. Simontacchi, F. Vianello, M. Basso, G.Z. Rambaldi, E. Russi, L. Tagliaferri

Research output: Contribution to journalArticle

Abstract

The therapeutic approach to thyroid carcinoma usually involves surgery as initial treatment. The use of external beam radiotherapy (EBRT) is limited to high-risk patients and depends on clinical stage and histologic type. Different behavior patterns and degrees of aggressiveness of thyroid carcinomas require different management for differentiated, medullary, and anaplastic carcinoma. However, the role of EBRT is an issue of debate. Most clinical studies are retrospective and based on single-institution experiences. In this article, we review the main literature and give recommendations for the use of EBRT in thyroid carcinoma on behalf of the "Radioterapia Metabolica" Group of the Italian Radiation Oncology Association. © 2017 Wichtig Publishing.
Original languageEnglish
Pages (from-to)114-123
Number of pages10
JournalTumori
Volume103
Issue number2
Early online dateMar 1 2017
DOIs
Publication statusPublished - Jan 29 2018

Fingerprint

Thyroid Neoplasms
Radiotherapy
Medullary Carcinoma
Radiation Oncology
Carcinoma
Therapeutics

Cite this

External beam radiotherapy in thyroid carcinoma: Clinical review and recommendations of the AIRO "Radioterapia Metabolica" Group. / Mangoni, M.; Gobitti, C.; Autorino, R.; Cerizza, L.; Furlan, C.; Mazzarotto, R.; Monari, F.; Simontacchi, G.; Vianello, F.; Basso, M.; Rambaldi, G.Z.; Russi, E.; Tagliaferri, L.

In: Tumori, Vol. 103, No. 2, 29.01.2018, p. 114-123.

Research output: Contribution to journalArticle

Mangoni, M, Gobitti, C, Autorino, R, Cerizza, L, Furlan, C, Mazzarotto, R, Monari, F, Simontacchi, G, Vianello, F, Basso, M, Rambaldi, GZ, Russi, E & Tagliaferri, L 2018, 'External beam radiotherapy in thyroid carcinoma: Clinical review and recommendations of the AIRO "Radioterapia Metabolica" Group', Tumori, vol. 103, no. 2, pp. 114-123. https://doi.org/10.5301/tj.5000532
Mangoni, M. ; Gobitti, C. ; Autorino, R. ; Cerizza, L. ; Furlan, C. ; Mazzarotto, R. ; Monari, F. ; Simontacchi, G. ; Vianello, F. ; Basso, M. ; Rambaldi, G.Z. ; Russi, E. ; Tagliaferri, L. / External beam radiotherapy in thyroid carcinoma: Clinical review and recommendations of the AIRO "Radioterapia Metabolica" Group. In: Tumori. 2018 ; Vol. 103, No. 2. pp. 114-123.
@article{d0fbad84b36e4c6cb759e1a0fa48144e,
title = "External beam radiotherapy in thyroid carcinoma: Clinical review and recommendations of the AIRO {"}Radioterapia Metabolica{"} Group",
abstract = "The therapeutic approach to thyroid carcinoma usually involves surgery as initial treatment. The use of external beam radiotherapy (EBRT) is limited to high-risk patients and depends on clinical stage and histologic type. Different behavior patterns and degrees of aggressiveness of thyroid carcinomas require different management for differentiated, medullary, and anaplastic carcinoma. However, the role of EBRT is an issue of debate. Most clinical studies are retrospective and based on single-institution experiences. In this article, we review the main literature and give recommendations for the use of EBRT in thyroid carcinoma on behalf of the {"}Radioterapia Metabolica{"} Group of the Italian Radiation Oncology Association. {\circledC} 2017 Wichtig Publishing.",
author = "M. Mangoni and C. Gobitti and R. Autorino and L. Cerizza and C. Furlan and R. Mazzarotto and F. Monari and G. Simontacchi and F. Vianello and M. Basso and G.Z. Rambaldi and E. Russi and L. Tagliaferri",
note = "Export Date: 26 February 2018 CODEN: TUMOA Correspondence Address: Gobitti, C.; Radiation Oncology Department, Centro di Riferimento Oncologico, Via F. Gallini 2, Italy; email: cgobitti@cro.it",
year = "2018",
month = "1",
day = "29",
doi = "10.5301/tj.5000532",
language = "English",
volume = "103",
pages = "114--123",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - External beam radiotherapy in thyroid carcinoma: Clinical review and recommendations of the AIRO "Radioterapia Metabolica" Group

AU - Mangoni, M.

AU - Gobitti, C.

AU - Autorino, R.

AU - Cerizza, L.

AU - Furlan, C.

AU - Mazzarotto, R.

AU - Monari, F.

AU - Simontacchi, G.

AU - Vianello, F.

AU - Basso, M.

AU - Rambaldi, G.Z.

AU - Russi, E.

AU - Tagliaferri, L.

N1 - Export Date: 26 February 2018 CODEN: TUMOA Correspondence Address: Gobitti, C.; Radiation Oncology Department, Centro di Riferimento Oncologico, Via F. Gallini 2, Italy; email: cgobitti@cro.it

PY - 2018/1/29

Y1 - 2018/1/29

N2 - The therapeutic approach to thyroid carcinoma usually involves surgery as initial treatment. The use of external beam radiotherapy (EBRT) is limited to high-risk patients and depends on clinical stage and histologic type. Different behavior patterns and degrees of aggressiveness of thyroid carcinomas require different management for differentiated, medullary, and anaplastic carcinoma. However, the role of EBRT is an issue of debate. Most clinical studies are retrospective and based on single-institution experiences. In this article, we review the main literature and give recommendations for the use of EBRT in thyroid carcinoma on behalf of the "Radioterapia Metabolica" Group of the Italian Radiation Oncology Association. © 2017 Wichtig Publishing.

AB - The therapeutic approach to thyroid carcinoma usually involves surgery as initial treatment. The use of external beam radiotherapy (EBRT) is limited to high-risk patients and depends on clinical stage and histologic type. Different behavior patterns and degrees of aggressiveness of thyroid carcinomas require different management for differentiated, medullary, and anaplastic carcinoma. However, the role of EBRT is an issue of debate. Most clinical studies are retrospective and based on single-institution experiences. In this article, we review the main literature and give recommendations for the use of EBRT in thyroid carcinoma on behalf of the "Radioterapia Metabolica" Group of the Italian Radiation Oncology Association. © 2017 Wichtig Publishing.

U2 - 10.5301/tj.5000532

DO - 10.5301/tj.5000532

M3 - Article

VL - 103

SP - 114

EP - 123

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 2

ER -